Compounds > cilostazol
Page last updated: 2024-10-25

cilostazol and Central Retinal Edema, Cystoid

cilostazol has been researched along with Central Retinal Edema, Cystoid in 1 studies

Research Excerpts

ExcerptRelevanceReference
"To evaluate the effects of cilostazol, an antiplatelet and vasodilation agent, on the retinal function of patients with non-proliferative diabetic retinopathy (NPDR) using a full-field electroretinogram (ffERG)."7.83The effect of cilostazol on electrophysiologic changes in non-proliferative diabetic retinopathy patients. ( Kim, HD; Kim, YK; Lee, SH; Oh, JR; Ohn, YH, 2016)
"To evaluate the effects of cilostazol, an antiplatelet and vasodilation agent, on the retinal function of patients with non-proliferative diabetic retinopathy (NPDR) using a full-field electroretinogram (ffERG)."3.83The effect of cilostazol on electrophysiologic changes in non-proliferative diabetic retinopathy patients. ( Kim, HD; Kim, YK; Lee, SH; Oh, JR; Ohn, YH, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, HD1
Lee, SH1
Kim, YK1
Oh, JR1
Ohn, YH1

Other Studies

1 other study available for cilostazol and Central Retinal Edema, Cystoid

ArticleYear
The effect of cilostazol on electrophysiologic changes in non-proliferative diabetic retinopathy patients.
    Documenta ophthalmologica. Advances in ophthalmology, 2016, Volume: 133, Issue:1

    Topics: Adult; Aged; Analysis of Variance; Atherosclerosis; Case-Control Studies; Cilostazol; Diabetes Melli

2016